Invesco Ltd. - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$326,780
+16.6%
68,364
+3.7%
0.00%
Q2 2023$280,271
-24.0%
65,946
-5.1%
0.00%
Q1 2023$368,849
+172.7%
69,463
+222.5%
0.00%
Q4 2022$135,277
-95.9%
21,541
-93.2%
0.00%
-100.0%
Q3 2022$3,324,000
+3224.0%
315,052
+1611.4%
0.00%
Q2 2022$100,000
-9.1%
18,409
+52.0%
0.00%
Q1 2022$110,00012,1130.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders